蝶腭神经节刺激器置入与强度设置的优化研究
本单臂多中心研究纳入50例前循环缺血性卒中患者,评估实时光学导航引导下蝶腭神经节电极置入及基于面部生理标志选择刺激强度的可行性。置入均准确且耗时短,96%患者可确定舒适耐受强度,刺激显著增加颈动脉血流并改善手部运动功能,第7天NIHSS恢复优于匹配历史对照。
要点
- 实时光学导航引导下蝶腭神经节电极置入快速且全部置入准确。
- 基于面部刺痛或流泪可确定舒适耐受强度,96%患者可行。
- 刺激显著增加颈动脉血流并改善握力与捏力,7天恢复优于历史对照。
核心结论
- 实时光学跟踪引导下蝶腭神经节刺激器置入快速准确,基于非伤害性面部刺痛与流泪选择刺激强度在几乎所有患者中可行。
- 蝶腭神经节刺激可增加颈颅血流并改善手部运动功能,第7天NIHSS恢复程度优于匹配历史对照。
研究设计与样本
- 单臂活性治疗试验,4个中心,纳入前循环缺血性卒中患者。
- 纳入标准为NIHSS 1至6分且手臂无力子项≥1分、未接受再通治疗、发病24小时内。
- 共纳入50例患者,年龄中位66岁(四分位距60-74),女性44%,NIHSS中位5分(四分位距4-5),发病至筛查时间中位18小时(四分位距9-20)。
主要发现
- 置入皮肤至皮肤时间中位4分钟(四分位距3-7),50例置入均正确。
- 96%患者基于生理标志确定舒适耐受强度,其中86%处于最佳低-中等强度范围。
- 刺激显著增加同侧颈总动脉收缩期峰值血流44%(P<0.0001)和舒张末期血流52%(P<0.0001)。
- 刺激显著改善捏力42%(P<0.0001)和握力26%(P<0.0001)。
- 第7天NIHSS恢复程度高于匹配历史对照,中位75% versus 50%,P=0.0003。
关键数值与推荐
- 刺激强度依据同侧面部刺痛感或流泪设定。
- 疗效评估包括超声测量同侧颈总动脉血流、患手握力与捏力及第1至7天NIHSS变化。
- 临床试验注册号NCT03551093。
临床怎么用
- 对未接受再通治疗的前循环缺血性卒中患者,可考虑光学导航引导下快速置入蝶腭神经节刺激器。
- 以面部刺痛或流泪等非伤害性生理标志个体化设定刺激强度,可能增加颈颅血流并改善手部运动功能。
局限性
- 本研究为单臂活性治疗试验,无同期随机对照,7天NIHSS恢复与历史对照比较。
- 样本量50例,随访仅至第7天,长期疗效未评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Two large, randomized trials indicated that sphenopalatine ganglion (SPG) stimulation improves final disability outcome in acute anterior circulation patients with ischemic stroke with confirmed cortical involvement. This study evaluated 2 refinements in SPG stimulation treatment technique: (1) SPG electrode placement with real-time optical tracking guidance; and (2) stimulation intensity comfortable tolerance level selection using non-noxious facial physiological markers. Methods- This study was a single, active arm trial at 4 centers, enrolling patients with anterior circulation ischemic stroke, National Institutes of Health Stroke Scale 1 to 6 including arm weakness subitem score ≥1, not receiving recanalization therapies, and within 24 hours of onset. Stimulation level was set based on ipsilateral facial tingling sensation or lacrimation. SPG stimulation effects were assessed by measuring volumetric blood flow in the ipsilateral common carotid artery by ultrasound and grasp and pinch strength in the affected hand before and during stimulation, and by change in National Institutes of Health Stroke Scale from day 1 to 7. Results- Among 50 enrolled patients, age was median 66 years (interquartile range, 60-74), 44% were female, National Institutes of Health Stroke Scale median was 5 (interquartile range, 4-5), and median onset-to-screening time was 18 hours (interquartile range, 9-20). Median implantation skin-to-skin time was 4 minutes (interquartile range, 3-7), and all 50 implants were placed correctly. Comfortable tolerance level was found based on physiological biomarkers in 96% of patients, including 86% in the optimal, low-medium intensity range. SPG stimulation significantly increased common carotid artery peak systolic and end-diastolic blood flow (44%, P<0.0001; and 52%, P<0.0001) and improved pinch strength (42%, P<0.0001) and grasp strength (26%, P<0.0001). Degree of National Institutes of Health Stroke Scale recovery by day 7 was greater than in matched historic controls, median 75% versus 50%, P=0.0003. Conclusions- SPG stimulator placement with real-time optical tracking guidance was fast and accurate, and selection of stimulation intensity levels based on non-noxious facial tingling and lacrimation was feasible in nearly all patients. SPG stimulation led to cervico-cranial blood flow augmentation and improved hand motor function. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT03551093.
引用
- Saver JL, Kharaishvili N, Janelidze T, et al. Refined Sphenopalatine Ganglion Stimulator Placement and Intensity Setting to Augment Blood Flow and Neurologic Function. Stroke. 2019. PMID: 31739771. doi:10.1161/STROKEAHA.119.027177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。